https://www.selleckchem.com/pr....oducts/wy-14643-piri
001), Ki67 ( =0.002), estrogen receptor (ER) ( =0.045) and P53 ( =0.032) were significant prognostic predictors for recurrence of endometrial cancer. The recurrence-free survival and the disease-specific survival of patients in the high-Ki67 group (Ki67 ≥38%) were much lower than those in the low-Ki67 group (Ki67 38%) ( =0.000, =0.001, respectively). Among the 118 patients with early low-risk endometrial cancer who did not receive adjuvant treatment after surgery, the recurrence-free survival of patients in the high-
Like
Comment
Share
